Search details
1.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37972660
2.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38517286
3.
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!
J Anat
; 242(4): 683-694, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36670522
4.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Article
in English
| MEDLINE | ID: mdl-36657420
5.
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.
Int J Mol Sci
; 24(8)2023 Apr 19.
Article
in English
| MEDLINE | ID: mdl-37108675
6.
Letter to the Editor Regarding the Article "Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement" by Zhou and Collaborators.
Ultraschall Med
; 44(6): 650-651, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-36377190
7.
Liver Fat Quantification: When do We Need It? / Leberfett-quantifizierung: Brauchen wir das?
Ultraschall Med
; 44(2): 120-124, 2023 04.
Article
in English, German
| MEDLINE | ID: mdl-36996835
8.
Ultrasound in clinical enviroments: Where are we standing? / Ultraschall im klinischen Umfeld: Wo stehen wir?
Ultraschall Med
; 44(4): 353-358, 2023 Aug.
Article
in English, German
| MEDLINE | ID: mdl-37552976
9.
Perirenal Ultrasound Abnormality: When to Think about Xanthogranulomatous Erdheim-Chester Disease.
Ultraschall Med
; 44(1): 91-93, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35882251
10.
Ultrasound, the handyman serving our whole populations in the post COVID-19 pandemic.
Ultraschall Med
; 42(6): 576-578, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34856626
11.
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
J Liver Cancer
; 24(1): 23-32, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38468499
12.
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study.
Dig Liver Dis
; 56(4): 571-578, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38151451
13.
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib.
Intern Emerg Med
; 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38551755
14.
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
Curr Oncol
; 31(1): 547-557, 2024 Jan 19.
Article
in English
| MEDLINE | ID: mdl-38275831
15.
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
JHEP Rep
; 6(2): 100982, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38274490
16.
TKIs in combination with immunotherapy for hepatocellular carcinoma.
Expert Rev Anticancer Ther
; 23(3): 279-291, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36794716
17.
Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art.
World J Gastroenterol
; 29(33): 4962-4974, 2023 Sep 07.
Article
in English
| MEDLINE | ID: mdl-37731994
18.
Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients.
Nutrients
; 15(6)2023 Mar 16.
Article
in English
| MEDLINE | ID: mdl-36986175
19.
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma.
Cancers (Basel)
; 15(5)2023 Feb 28.
Article
in English
| MEDLINE | ID: mdl-36900314
20.
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
J Hepatocell Carcinoma
; 10: 473-482, 2023.
Article
in English
| MEDLINE | ID: mdl-37007210